Overview

Liposome Bupivacaine for WRIST Blocks

Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
Treatment of Dupuytren's contracture requires multiple injections into the palm of the hand to weaken the cords, followed by rupture of the strands 2 days later. Anesthesia is required for both phases of treatment. It is hypothesized that extended-release liposome bupivacaine prolongs nerve blockade of the wrist allowing patients to undergo this 2-part regimen with less pain.
Phase:
Phase 2
Details
Lead Sponsor:
Admir Hadzic, M.D., Ph.D.
Catherine Vandepitte, M.D.
Collaborator:
Pacira Pharmaceuticals, Inc
Treatments:
Bupivacaine